Europe miRNA Sequencing and Assay Market was valued at USD 0.6 Billion in 2022 and is projected to reach USD 1.5 Billion by 2030, growing at a CAGR of 12.3% from 2024 to 2030.
The Europe miRNA Sequencing and Assay Market has emerged as a significant player in the biotechnology and healthcare sectors, driven by the increasing demand for precision medicine and genetic research. miRNA sequencing plays a crucial role in understanding the molecular mechanisms behind various diseases and disorders, especially cancer, neurological diseases, and cardiovascular diseases. By identifying and analyzing miRNAs, which regulate gene expression, this technology is helping to unlock new therapeutic targets, diagnostic markers, and treatment strategies.
In Europe, the market for miRNA sequencing is growing rapidly, fueled by advancements in sequencing technologies, the expanding number of research institutions, and rising healthcare expenditures. miRNA assays are being increasingly adopted across industries like pharmaceuticals, diagnostics, and research due to their ability to provide valuable insights into gene regulation and cellular processes. A key driver for this market is the growing need for personalized medicine and companion diagnostics, where miRNA profiling is used to predict patient responses to treatments.
The demand for miRNA sequencing and assays is not limited to research and academia but is also expanding into the clinical diagnostics space. Hospitals and diagnostic centers are increasingly adopting miRNA-based assays to detect and monitor diseases like cancer at earlier stages. As the cost of sequencing technology decreases and the efficiency improves, these assays are becoming more accessible for routine clinical applications.
Industries such as pharmaceuticals and biotechnology companies are also major contributors to the growth of the miRNA sequencing market. They require these assays for drug development and biomarker discovery. With personalized treatment approaches gaining popularity, companies are investing heavily in the development of miRNA-based therapeutics and diagnostic tools.
As the miRNA sequencing and assay market continues to evolve, a clear trend toward automation and high-throughput technologies is emerging. These innovations enable faster and more accurate data analysis, essential for meeting the growing demand from both research and clinical industries. Furthermore, collaborations between industry players and academic institutions are strengthening the overall ecosystem, fostering growth and innovation.
Given the increasing importance of miRNA in understanding and diagnosing complex diseases, the Europe miRNA Sequencing and Assay Market is poised for substantial growth. As more industries recognize the potential of miRNA sequencing, the market will continue to evolve, meeting the needs of both the research and clinical sectors.
Get an In-Depth Research Analysis of the Europe miRNA Sequencing and Assay Market Size And Forecast [2025-2032]
Â
Illumina
Thermo Fisher Scientific
Qiagen
Perkinelmer
Takara Bio
Ew England Biolabs
Norgen Biotek Corporation
Rilink Biotechnologies
Exogen
Oxford Nanopore Technologies
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe miRNA Sequencing and Assay Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe miRNA Sequencing and Assay Market
Next-generation sequencing (NGS)
Microarray-based sequencing
Quantitative PCR
Oncology
Cardiovascular diseases
Neurological disorders
Infectious diseases
Others (including genetic research and diagnostics)
Academic research institutes
Pharmaceutical and biotechnology companies
Hospitals and diagnostic laboratories
Contract research organizations (CROs)
Consumables
Instruments
Software
Services
Pre-sequencing
Sequencing
Post-sequencing
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ miRNA Sequencing and Assay Market Research Analysis
1. Introduction of the Europe miRNA Sequencing and Assay Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe miRNA Sequencing and Assay Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe miRNA Sequencing and Assay Market, By Type
6. Europe miRNA Sequencing and Assay Market, By Application
7. Europe miRNA Sequencing and Assay Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Europe miRNA Sequencing and Assay Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Europe Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/